HUMANA INC 8-K

What Happened
Humana Inc. (HUM) filed an 8-K on April 10, 2026, announcing that its Board expanded from ten to eleven authorized directors and elected Robert S. Field as a director, effective immediately after the adjournment of the Humana 2026 Annual Meeting of Stockholders on April 16, 2026. The Board has concluded Mr. Field qualifies as an independent director under NYSE standards.

Key Details

• Filing date: April 10, 2026; effective immediately following adjournment of the April 16, 2026 Annual Meeting.
• Board size increased from 10 to 11 directors.
• New director: Robert S. Field; deemed independent by the New York Stock Exchange standards.
• Compensation: Mr. Field will be paid under Humana’s existing director compensation program and will receive restricted stock units (RSUs) as described in Humana’s proxy filed March 6, 2026.
• No committee assignments have been made yet; company discloses no arrangements or related-party transactions involving Mr. Field.

Why It Matters
Board composition and independence are key governance factors for investors. Adding an independent director can affect board oversight, committee composition, and corporate governance dynamics. The disclosure of RSU-based compensation follows the company’s established proxy-stated program, and the company reported no material transactions or special arrangements involving the new director.